All In MedTech

FDA Clearance Tracker · K113480

SPECTRA OPTIA APHERESIS SYSTEM

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jan 20, 2012 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jan 20, 2012

Substantially Equivalent

Time to decision

58 days

Received Nov 23, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Unclassified

The decision

FDA number
K113480
Device name
SPECTRA OPTIA APHERESIS SYSTEM
Applicant location
Lakewood, CO
Received
Nov 23, 2011
Decided
Jan 20, 2012
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Unclassified

Every decision under product code LKN

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LKN. The earliest in FDA's data is P810023, decided Mar 16, 1982.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Caridianbct, Inc..

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.